GlobeNewswire
KINGSONG Launches Four Next-Generation Electric Unicycles, Setting a New Benchmark for Intelligent Mobility
📈
AI Sentiment
Highly Positive
8/10
- Home
- IMMX
IMMX
Immix Biopharma Inc.
as of 12-04-2025 3:46pm EST
$4.83
+$0.68
+16.39%
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
Chart Type:
Time Range:
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | LOS ANGELES |
| Market Cap: | 82.6M | IPO Year: | 2021 |
| Target Price: | $8.00 | AVG Volume (30 days): | 613.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.78 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.34 - $5.05 | Next Earning Date: | 11-07-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered IMMX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 74.50%
74.50%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Immix Biopharma Inc. (IMMX)
Rachman Ilya M
Buy
CEO and Chairman
IMMX Sep 17, 2025
Avg Cost/Share
$2.02
Shares
2,500
Total Value
$5,050.00
Owned After
1,140,937
SEC Form 4
Morris Gabriel S
Buy
CFO
IMMX Sep 16, 2025
Avg Cost/Share
$1.97
Shares
2,600
Total Value
$5,122.00
Owned After
290,659
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Rachman Ilya M | IMMX | CEO and Chairman | Sep 17, 2025 | Buy | $2.02 | 2,500 | $5,050.00 | 1,140,937 | |
| Morris Gabriel S | IMMX | CFO | Sep 16, 2025 | Buy | $1.97 | 2,600 | $5,122.00 | 290,659 |
Latest Immix Biopharma Inc. News
IMMX Breaking Stock News: Dive into IMMX Ticker-Specific Updates for Smart Investing
24/7 Wall St.
XRP Price Target December 2025: ChatGPT AI Predicts $2.02 vs Analysts’ $2.85
➖
AI Sentiment
Neutral
5/10
CNW Group
Various pistachios and pistachio-containing products recalled due to Salmonella
📉
AI Sentiment
Negative
2/10
Pioneer Press, St. Paul, Minn.
Small Business Saturday spotlight: New women’s boutique on Grand Avenue
📈
AI Sentiment
Highly Positive
8/10
GuruFocus.com
Net Power: Headwinds And Delays Doesn't Distort Long-Term Potential
📊
AI Sentiment
Positive
7/10
Compare IMMX vs Leading Stocks
See how IMMX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "IMMX Immix Biopharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.